BibTex RIS Cite

Sağlık Alanında Biyoteknolojik Uygulamalar: Kırmızı Biyoteknoloji

Year 2014, Volume: 1 Issue: 1, 66 - 70, 01.07.2016

Abstract

Biyoteknoloji canlı materyallerin kullanımıyla ekonomik değeri olan ürünlerin üretimini içeren süreçleri kapsayan bilim dalıdır. Son yıllarda özellikle genetik tekniklerin geliştirilmesiyle birlikte bir organizmadan diğerine genetik materyallerin transferi ve ticari öneme sahip yeni metabolitlerin üretiminin optimizasyonu için uygun organizmaların varlığı biyoteknolojik uygulamalara hız kazandırmıştır. Bu çalışmada biyoteknolojinin sağlık alanında gerçekleştirilen uygulamalarını kapsayan kırmızı biyoteknoloji üzerine genel bir derleme yapılmıştır.

References

  • Emtiazi, G., Principle of genetic engireeing and molecular biology., 2 nd ed.,Giti press, 2011.
  • Gartland, K.M.A. , Bruschi, F., Dundar, M. , Gahan, P.B., Viola Magni, M.P., Akbarova, Y., “Progress towards the„Golden Age‟ of biotechnology”, Current Opinion in Biotechnology., vol. 24, pp. 6-13, 2013.
  • Scott, K., Handbook of Industrial Membranes, 2 nd ed., 14, pp. 655- 680, 1998.
  • Kolankaya, N.,“KüreselleĢme Sürecinde Biyoteknoloji ve Biyogüvenlik'', Biyoteknolojiye Bir Bakış: Dünya ve Türkiye Sempozyum Bildirileri Kitabı, T.C. Çevre Bakanlığı, T.C. Tarım ve KöyiĢleri Bakanlığı ve Biyoteknoloji Derneği Ortak Yayınları, Ankara, pp. 1- 6, 2000.
  • Akkaya, A., Pazarlıoğlu, N., “21.Yüzyılın Anahtar Teknolojisi:Beyaz Biyoteknoloji”, Kırıkkale Üniversitesi Bilimde Gelişmeler Dergisi, pp. 22- 33, 2012.
  • Zand, M., Narasu, M., “A review article Biotechnology Applications in Medicine”, Intl. Res. J. Appl. Basic. Sci., 4(9), pp. 2557-2563, 2013.
  • King, G.D., Curtin, J.F., Candolfi, M., Kroeger, K., Lowenstein, P.R., Castro, M.G., “Gene therapy and targeted toxins for glioma”, Curr. Gene Ther., 5(6), pp. 535-57, 2005.
  • The Genetics Home website. [online]. http://ghr.nlm.nih.gov/handbook/therapy/genetherapy, eriĢim tarihi: 2007.
  • The Cancer Institute website. [online]. http://www.cancer.gov/cancertopics/factsheet/Therapy/Gene, eriĢim tarihi:10.09.2008.
  • Watters, J.W., McLeod, H.L., “Cancer pharmacogenomics: Current and future applications”, Biochim. Biophys. Acta.,vol. 1603(2), pp. 99-111, 2003.
  • Chasman, D. I., Posada, D., Subrahmanyan, L., Cook, N. R., Stanton, V. P., Ridker, P. M., “Pharmacogenomics study of statin therapy and cholesterol reduction”, JAMA, 291(23), pp. 2821-2827, 2004.
  • Mancama, D., Kerwin, R.W., “Role of pharmacogenomics in individualising treatment with SSRIs”, CNS Drugs, vol.17(3), pp. 143-51, 2003.
  • Anderson, J.L., Carlquist, J.F., Horne, B.D., Muhlestein, J.B., “Cardiovascular pharmacogenomics: current status, future prospects”, J. Cardiovasc. Pharmacol. Ther., vol. 8(1), pp. 71-83. 2003.
  • Wolf, C.R., Smith, G., Smith, R.L., “Science, medicine and the future, Pharmacogenetics”, Br. Med. J., vol. 320, pp. 987-990, 2000.
  • Tessari, A., Palmieri, D., Di Cosimo, S., “Overview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patients”, Pharmacogenomics and Personalized Medicine.,vol. 7, pp. 1–19, 2014.
  • Vincent-Gattis, M. , Webb, C. , Foote, M.A., “Clinical research strategies in biotechnology”, Biotechnology Annual Review,vol. 5, pp. 259–267, 2000.
  • Handman, E., ''Leishmaniasis: Current Status of Vaccine Development'', Clinical microbiology review, pp. 229–243, 2001.
  • Ho, R.J.Y, Gibaldi, M., Biotechnology
  • Recombivax., [online]. http://www.merck.com/product/usa/pi_circulars/r/recombivax_hb/recombivax_pi.pdf, eriĢim tarihi: 08.05. 2014.
  • Comvax., [online]. http://www.merck.com/product/usa/pi_circulars/c/comvax/comvax_pi.pdf ,eriĢim tarihi: 08.05. 2014.
  • Engerix-, B., [online]. http://www.gsk.ca/english/docs-pdf/product-monographs/Engerix-B.pdf ,eriĢim tarihi: 08.05. 2014.

Biotechnological Applications in the Field of Health: Red Biotechnology

Year 2014, Volume: 1 Issue: 1, 66 - 70, 01.07.2016

Abstract

Biotechnology is a scientific discipline which covers the production processes of economically valuable products. Recently, especially together with the developments of genetic techniques like the transfer of genetic material one organism to another and avaliabilty of organisms for the production of commercially important new metabolites provides speed to biotechnological applications. In this study red biotechnology including biotechnological applications in the field of health reviewed in general.

References

  • Emtiazi, G., Principle of genetic engireeing and molecular biology., 2 nd ed.,Giti press, 2011.
  • Gartland, K.M.A. , Bruschi, F., Dundar, M. , Gahan, P.B., Viola Magni, M.P., Akbarova, Y., “Progress towards the„Golden Age‟ of biotechnology”, Current Opinion in Biotechnology., vol. 24, pp. 6-13, 2013.
  • Scott, K., Handbook of Industrial Membranes, 2 nd ed., 14, pp. 655- 680, 1998.
  • Kolankaya, N.,“KüreselleĢme Sürecinde Biyoteknoloji ve Biyogüvenlik'', Biyoteknolojiye Bir Bakış: Dünya ve Türkiye Sempozyum Bildirileri Kitabı, T.C. Çevre Bakanlığı, T.C. Tarım ve KöyiĢleri Bakanlığı ve Biyoteknoloji Derneği Ortak Yayınları, Ankara, pp. 1- 6, 2000.
  • Akkaya, A., Pazarlıoğlu, N., “21.Yüzyılın Anahtar Teknolojisi:Beyaz Biyoteknoloji”, Kırıkkale Üniversitesi Bilimde Gelişmeler Dergisi, pp. 22- 33, 2012.
  • Zand, M., Narasu, M., “A review article Biotechnology Applications in Medicine”, Intl. Res. J. Appl. Basic. Sci., 4(9), pp. 2557-2563, 2013.
  • King, G.D., Curtin, J.F., Candolfi, M., Kroeger, K., Lowenstein, P.R., Castro, M.G., “Gene therapy and targeted toxins for glioma”, Curr. Gene Ther., 5(6), pp. 535-57, 2005.
  • The Genetics Home website. [online]. http://ghr.nlm.nih.gov/handbook/therapy/genetherapy, eriĢim tarihi: 2007.
  • The Cancer Institute website. [online]. http://www.cancer.gov/cancertopics/factsheet/Therapy/Gene, eriĢim tarihi:10.09.2008.
  • Watters, J.W., McLeod, H.L., “Cancer pharmacogenomics: Current and future applications”, Biochim. Biophys. Acta.,vol. 1603(2), pp. 99-111, 2003.
  • Chasman, D. I., Posada, D., Subrahmanyan, L., Cook, N. R., Stanton, V. P., Ridker, P. M., “Pharmacogenomics study of statin therapy and cholesterol reduction”, JAMA, 291(23), pp. 2821-2827, 2004.
  • Mancama, D., Kerwin, R.W., “Role of pharmacogenomics in individualising treatment with SSRIs”, CNS Drugs, vol.17(3), pp. 143-51, 2003.
  • Anderson, J.L., Carlquist, J.F., Horne, B.D., Muhlestein, J.B., “Cardiovascular pharmacogenomics: current status, future prospects”, J. Cardiovasc. Pharmacol. Ther., vol. 8(1), pp. 71-83. 2003.
  • Wolf, C.R., Smith, G., Smith, R.L., “Science, medicine and the future, Pharmacogenetics”, Br. Med. J., vol. 320, pp. 987-990, 2000.
  • Tessari, A., Palmieri, D., Di Cosimo, S., “Overview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patients”, Pharmacogenomics and Personalized Medicine.,vol. 7, pp. 1–19, 2014.
  • Vincent-Gattis, M. , Webb, C. , Foote, M.A., “Clinical research strategies in biotechnology”, Biotechnology Annual Review,vol. 5, pp. 259–267, 2000.
  • Handman, E., ''Leishmaniasis: Current Status of Vaccine Development'', Clinical microbiology review, pp. 229–243, 2001.
  • Ho, R.J.Y, Gibaldi, M., Biotechnology
  • Recombivax., [online]. http://www.merck.com/product/usa/pi_circulars/r/recombivax_hb/recombivax_pi.pdf, eriĢim tarihi: 08.05. 2014.
  • Comvax., [online]. http://www.merck.com/product/usa/pi_circulars/c/comvax/comvax_pi.pdf ,eriĢim tarihi: 08.05. 2014.
  • Engerix-, B., [online]. http://www.gsk.ca/english/docs-pdf/product-monographs/Engerix-B.pdf ,eriĢim tarihi: 08.05. 2014.
There are 21 citations in total.

Details

Other ID JA49BT28MM
Journal Section Articles
Authors

Ülküye Dudu Gül This is me

Publication Date July 1, 2016
Submission Date July 1, 2016
Published in Issue Year 2014 Volume: 1 Issue: 1

Cite

APA Gül, Ü. D. (2016). Sağlık Alanında Biyoteknolojik Uygulamalar: Kırmızı Biyoteknoloji. Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi, 1(1), 66-70.